Page 8 - Directa Plus Plc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional bod...

The human patch test on volunteers did not show skin erythema and oedema reactions Directa Plus PLC (LON:DCTA) announced its new G+ graphene coating for fabrics was tested by an independent third party laboratory and found to be suitable for human skin contact. The human patch test on volunteers was carried out to assess any potential side effects, such as skin erythema and oedema reactions. None occured. The fabric was reported to be 'dermatologically tested' and non-irritating. The graphene company said the G+ coating was developed specifically for the automotive, upholstery, interior d...

9 April 2021 | 08:02am StockMarketWire.com - Graphene nanoplatelets based-products supplier Directa Plus said it had appointed Giorgio Bonfanti as chief financial officer starting 31 May 2021. Bonfanti has been employed by the global accountancy network PwC since 2014, working out of their Milan office. His most recent role was as a senior manager in their deals practice. At 8:02am: [LON:DCTA] Directa Plus Plc share price was 0p at 61p Story provided by StockMarketWire.com Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. Latest share price and company details:

22 February 2021 | 08:04am StockMarketWire.com - Graphene nanoplatelets products maker Directa Plus said it had has signed a supply and a strategic R&D with battery maker NexTech Batteries. Under the supply agreement, with an initial duration of three years and an option to extend for an additional two years, Directa Plus would supply 300kg of nanoplatelets in 2021 to NexTech for the production to be used in the production the latter's first generation of Li-S batteries. Quantities for delivery in each subsequent year would be agreed between the parties at the end of each year. NexTech wa...

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional bod...